Xin‐Mei Yang

Neuron-derived neuropeptide Y fine-tunes the splenic immune responses

Jinsong Yu, Ke Xiao, Xiaohua Chen et al. · Neuron · 2022 · 54 citations

Life Sciences, Immunology, Neuroscience +14

A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects

Xin‐Mei Yang, Yang Yang, Bu‐Fan Yao et al. · European Journal of Pharmaceutical Sciences · 2023 · 26 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +16

Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study

Xin‐Mei Yang, Stéphanie Leroux, Thomas Storme et al. · Antimicrobial Agents and Chemotherapy · 2019 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial

Jia Zhong, Kailun Fei, Lin Wu et al. · Signal Transduction and Targeted Therapy · 2024 · 15 citations · Full text

Medicine, Molecular Medicine, Oncology +17

[Clinical significance of protein Z detection in patients with malignant tumors].

Yi Shang, Cai-ping Ding, Xin‐Mei Yang et al. · PubMed · 2005 · 12 citations

Medicine, Hematology, Oncology +15